Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
15 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Elahere“
Suchtreffer
Begriffe & Kennungen
Elahere · 4.8 · Permanent discontinuation due to an adverse reaction occurred in 12% of patients who received mirvetuximab sor
Eintrag öffnenElahere · 4.8 · Pneumonitis
Eintrag öffnenElahere · 4.8 · Pneumonitis (grouped terms) occurred in 10% of patients with EOC treated with mirvetuximab soravtansine, inclu
Eintrag öffnenElahere · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenElahere · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenElahere · 4.8 · Summary of safety profile
Eintrag öffnenElahere · 4.8 · Table 4: Tabulated list of all grade adverse reactions in patients treated with mirvetuximab soravtansine in c
Eintrag öffnenElahere · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenElahere · 4.8 · The adverse reaction frequencies from clinical studies are based on all-cause adverse event frequencies, for w
Eintrag öffnenElahere · 4.8 · The frequencies of adverse reactions are based on pooled data from 4 clinical studies which included 682 patie
Eintrag öffnenElahere · 4.8 · The median time to onset for first ocular adverse reaction was 5.1 weeks (range: 0.1 to 68.6). Of the patients
Eintrag öffnenElahere · 4.8 · The median time to onset of peripheral neuropathy was 5.9 weeks (range 0.1 to 126.7). Peripheral neuropathy re
Eintrag öffnenElahere · 4.8 · The median time to onset of pneumonitis was 18.1 weeks (range 1.6 to 97.0). Pneumonitis resulted in mirvetuxim
Eintrag öffnenElahere · 4.8 · The most common adverse reactions with mirvetuximab soravtansine were blurred vision (43%), nausea (41%), diar
Eintrag öffnenElahere · 4.8 · The most commonly reported serious adverse reactions were pneumonitis (4%), small intestinal obstruction (3%),
Eintrag öffnen